Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Sona Nanotech Inc. is a nanotechnology life sciences company that has developed multiple methods for the manufacturing of various types of gold nanoparticles. The Company is engaged in the research and development of its technology for use in multiplex diagnostic testing platforms and biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of CTAB (cetyltrimethylammonium), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company leverages its core proprietary gold nanorod (GNR) manufacturing technology and laboratory assets to focus on the development of diagnostic tests and biologic reagents, and the advancement of its GNR intellectual property.


CSE:SONA - Post by User

Comment by TheeRookon Jul 15, 2020 3:26pm
96 Views
Post# 31272379

RE:RE:RE:RE:RE:RE:Hmmmm.....

RE:RE:RE:RE:RE:RE:Hmmmm..... Depends on the price?  What are BD and Qdel  pricing.

3M / MIT paper based one will be really cheap, making it  more suitable for donating to poor countries   by NGOs ,  etc...


datawork wrote:

At this point in the game, I think we can safely say that oders wil be in excess of 100M. Taking into consideration that Covid is running rampent in the States and many other parts of the world. Flu season is just around the corner and a vaccine is at least a year away at best. 

I'm also would not be at all surprised to see pr's regarding partnering, licence agreements given the HUGE demand for quick, accurate, afforable testing. 

Hold on, this is going to be the ride of a lifetime.

GLTA



<< Previous
Bullboard Posts
Next >>